Roivant Sciences Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	8.26	29.05	32.71	61.28	55.29
Revenue Growth (YoY)	-71.57%	-11.19%	-46.62%	10.84%	132.34%
Cost of Revenue	1.29	0.91	1.6	13.13	8.97
Gross Profit	6.98	28.14	31.11	48.15	46.32
Selling, General & Admin	610.47	591.41	416.13	600.51	775.03
Research & Development	681.81	550.41	466.36	622.96	622.93
Other Operating Expenses	-770.24	-110.39	-5,348	-	-
Total Operating Expenses	522.04	1,031	-4,466	1,223	1,398
Operating Income	-515.07	-1,003	4,497	-1,175	-1,352
Interest Income	178.11	258.38	146.43	32.18	0.37
Interest Expense	-	-	-	-27.97	-7.04
Other Non-Operating Income (Expense)	72.38	63.33	-75.6	-53.73	434.57
Total Non-Operating Income (Expense)	250.49	321.7	70.82	-49.52	427.9
Pretax Income	-264.58	-681.59	4,568	-1,225	-923.75
Provision for Income Taxes	133.33	48.17	21.5	5.19	0.37
Net Income	-397.91	-729.76	4,546	-1,230	-924.12
Minority Interest in Earnings	-98.14	-184.75	-117.72	-106.43	-78.85
Earnings From Discontinued Operations	-	373.03	-315.15	114.56	-
Net Income to Common	-299.77	-171.98	4,349	-1,009	-845.26
Shares Outstanding (Basic)	694	725	783	713	670
Shares Outstanding (Diluted)	694	725	831	713	670
Shares Change (YoY)	-4.35%	-12.71%	16.59%	6.43%	6.30%
EPS (Basic)	-0.43	-0.24	5.55	-1.42	-1.26
EPS (Diluted)	-0.54	-0.24	5.23	-1.42	-1.26
Free Cash Flow	-758.56	-844.05	-766.65	-856.08	-695.17
Free Cash Flow Per Share	-1.09	-1.16	-0.92	-1.20	-1.04
Gross Margin	84.44%	96.86%	95.11%	78.58%	83.78%
Operating Margin	-6235.69%	-3453.32%	13746.90%	-1917.95%	-2444.82%
Profit Margin	-4817.28%	-2511.84%	13897.70%	-2007.22%	-1671.52%
FCF Margin	-9183.51%	-2905.21%	-2343.56%	-1397.00%	-1257.40%
EBITDA	-511.72	-989.22	4,519	-1,156	-1,346
EBITDA Margin	-6195.16%	-3404.89%	13814.30%	-1887.18%	-2434.09%
EBIT	-515.07	-1,003	4,497	-1,175	-1,352
EBIT Margin	-6235.69%	-3453.32%	13746.90%	-1917.95%	-2444.82%
Effective Tax Rate	-50.39%	-7.07%	0.47%	-0.42%	-0.04%

SEC Filings: 10-K · 10-Q